Andrew Haller

Andrew Haller

@andrew-hallerProgram Manager
Events - Sep 18, 2017
Exciting opportunity for a Medtech trade mission to Japan! Contact [email protected] (+1 416-325-6782) for more information or registration Dear friends, In partnership with Global Affairs Canada, and supported by JETRO, Osaka Prefectural Government, Reed Exhibitions, TOHealth! and other industrial association partners, Ontario is organizing a Health Trade Mission to Japan and Korea, targeting business opportunities in these two important markets. You are cordially invited to join with us. This would be of particular interest to Ontario companies that provide products/services/technologies (such as Medical Imaging, Health IT etc.) to healthcare, clinical testing, diagnostics and medicine industries. Why attend? file:///C:\Users\ahall\AppData\Local\Temp\OICE_BBF1028B-3AE0-4C5B-9A9C-3EC55F61FD2C.0\msohtmlclip1\01\clip_image002.pngMarkets · Valued at US$527 billion, Japan is the world’s 3rd largest medical market with high stability. In addition, the ever increasing rate of aged population drives the medical needs resulting in expansion and construction of new hospitals and nursing homes. · Imported medical devices account 49% of the Japanese market. The Japanese medical device market relies heavily on imported products. In 2014, the imported products were valued at US$12.3 billion. · file:///C:\Users\ahall\AppData\Local\Temp\OICE_BBF1028B-3AE0-4C5B-9A9C-3EC55F61FD2C.0\msohtmlclip1\01\clip_image004.pngShortened approval process time. In late 2014, the Japanese government revised the Pharmaceutical Affairs Law (PAL) and implemented the new PMD Act (“Act on Securing Quality Efficacy and Safety of Pharmaceuticals, Medical Devices, Regenerative and Cellular Therapy Products, Gene Therapy Products, and Cosmetics”), to shorten and standardize the review time for medical device approval. This will greatly help foreign medical device companies get their products on the Japanese market sooner. · Increasing demand on healthcare and medical technologies in Korea. The medical devices market has grown steadily in Korea - 6.2% compund annual growth rate (CAGR) between 2010 and 2015 (US$4.65 billion). · Market growth driven by an ageing population (Korea ranked first among OECD countries in aging population growth rate) and growth in the medical devices industry engaged in other emerging countries. file:///C:\Users\ahall\AppData\Local\Temp\OICE_BBF1028B-3AE0-4C5B-9A9C-3EC55F61FD2C.0\msohtmlclip1\01\clip_image006.pngPrograms & Services · A well-designed Ontario / Canada pavilion you will be exhibiting and presenting in. · A well-positioned consulting firm will be hired to provide detailed market information and assist mission members to be introduced to key contacts in the industry. · Business 2 business meetings will be set up for mission members. · Interpretation services will be provided for mission members in the pavilion and related programs to facilitate your discussion with local business contacts. · Media exposure will be provided for mission members in the pavilion and related programs to facilitate your discussion with local business contacts. · An Industry seminar and networking event co-hosted with the Osaka Prefectural government · A site visit to a hospital or senior house to hear about user voices (TBC). · Medical Japan (http://www.medical-jpn.jp/en/) although only with a few years history, the trade event has grown to be one of the most important healthcare shows in Japan. Medical Japan 2017 hosted 1,067 exhibitors (medical devices and technology, health IT, hospital/nursing home suppliers etc.) and was visited by 29,000+ visitors (hospitals, manufacturers, importers and distributors etc.) Concurrent Expos within Medical Japan 2018 3rd medical IT Solutions Expo 4th Hospital +Innovation Expo 8th Medical Device Development Expo Osaka 4th Int’l Pharmaceutical R&D and Manufacturing Expo Osaka 4th Regenerative Medicine Expo & Conference Japan 4th Elderly Care + Nursing Expo Japan Cost · Low participation fee ($1,000 per company, early bird rate) on companies as Ontario will cover major program expenses (show spaces and all services listed above). About the Markets In September or October, a webinar/seminar will be hosted (in partnership with JETRO) to provide some more information about Japanese healthcare market. There are also a few reports available on export.gov webpage that provide good/basic market intelligence. Please click on the hyperlink to view the complete article. · Japan - Healthcare ITJapan - Healthcare IT · Japan - Pharmaceutical · Korea - Medical Equipment and Devices · Health IT Country Case Study Challenges and Barriers – South Korea Proposed Mission Itinerary (Version 3) · February 20 (Tue) Osaka a.m. Life Sciences Seminar co-organized with Osaka Prefectural Government and life Sciences Cluster Networking Lunch p.m. Business to business meetings Venue: TBD p.m. Booth set up at Medical Japan · February 21-23 (Wed-Fri) Osaka Exhibition at Ontario Pavilion at Medical Japan Individual B2B meetings Venue: INTEX Osaka · February 26 (Mon) Seoul 9:00am Market Briefing by Trade Commissioners Canadian Embassy in Korea 10:30am Briefing with industry association, educational institutions, other industry players (TBD) 12:30pm Lunch 2.00pm Individual/group meetings (TBC). Participation fee $1000 per company (early bird rate till September 15th, 2017) Potential Funding Two funding programs for your consideration: Export Market Access (EMA) is an initiative of the Ontario Chamber of Commerce, with support and funding from the Government of Ontario. It is designed to assist small to medium size organizations (SMEs) to access and expand their growth in new foreign markets. Companies with annual sales of $500,000 or more may qualify for a grant covering up to 50% of the direct costs of accessing and expanding into export markets (up to C$30,000). For more details and to apply, please visit: www.exportaccess.ca CanExport : Starting from January 2016, CanExport is a new program delivered by the Trade Commissioner Service (TCS) of Global Affairs Canada, in partnership with the National Research Council Industrial Research Assistance Program (NRC-IRAP). The funding program will provide up to $50 million over five years in direct financial support to small and medium-sized enterprises (SMEs) in Canada seeking to develop new export opportunities, particularly in high-growth priority markets and sectors. . Please consult the applicant guide to determine your eligibility. http://international.gc.ca/trade-commerce/funding-financement/canexport/index.aspx?lang=eng Contact: Please contact [email protected] (+1 416-325-6782) for more information or registration

Aug 21, 2017
Life science companies interested in exporting medical devices to Europe can find out more about the ins and outs of the processes involved by taking part in a couple of workshops being offered by the Ontario government. The two workshops, Medical Device Reimbursement and CE Marketing will be held on September 7th and September 14th, respectively at the Ontario Trade and Investment Centre (OITC) on 250 Yonge Street in Toronto. The workshops are from 8 a.m. to 4 p.m. and include breakfast, lunch, and coffee breaks. There is a fee of $40, plus HST. During the medical device reimbursement workshop, attendees will learn about the reimbursement requirements in Germany, the United Kingdom, and France. Michael Weiber, chief operating officer of avionics and simulation modules manufacturer, AiM GmbH, will provide an overview of the complex reimbursement schemes in Europes largest markets. The CE marketing workshop will tackle issues associated with the revision of the Medical Devices Directives for the EU. Familiarity with the directives becomes important with the implementation of the Comprehensive Economic Trade Agreement (CETA) between Canada and the EU which will soon open up further opportunities for Canadian companies. Manuel Ahlers, lead senior auditor of certification company, Turv Nord, will provide an overview of the new requirements of the EU regulatory system, and an implementation strategy for dealing with QM-related requirements. These workshops are ideal for small and medium sized enterprises that export or intend to export medical devices to European Union countries. For more information, contact Patrick Barry, Ministry of International Trade area director for Europe, via phone at 416-326-1075 or email [email protected]

Funding - May 30, 2017
Hola, Bonjour, Hello, TECNIOSPRING PLUS We are pleased to inform you that a new edition of the TECNIOspring PLUS programme will be launched in June 2017 (see attached). All the information about the programme and the results of previous calls can be found at www.tecniospring.eu. Interested candidates may contact [email protected] for further information. TECNIOspring PLUS is a mobility programme co-funded by the European Union (H2020 – Marie Sklodowska-Curie Actions), which aims to foster the mobility of experienced researchers. The programme is managed by ACCIÓ, Catalonia Trade & Investment Agency, attached to the Government of Catalonia. TECNIOspring PLUS offers 2-year employment contracts to experienced researchers in order to develop an applied research project with focus on technology transfer. Worldwide researchers may join anyCatalan company or technological centre accredited with the TECNIO recognition during 2 years (Incoming fellowship). National and international research centres and R&D departments of private companies worldwide can also welcome a fellow during the 1st year, followed by a return phase to a Catalan company or a TECNIO centre during the 2nd year (Outgoing +Return fellowship). The programme has already granted more than 60 participants on the previous calls and applications from women are encouraged. UNILATERAL NUCLIS NUCLIS, the Call for Industrial Research and Experimental Development Funding in Catalonia, will be launched towards the beginning of June 2017 (see attached for more information). Nuclis grants are available for TRL3 to TRL7, and finance R&D projects to obtain prototypes and demonstrations of new products, processes, technologies. The aim is to promote R&D partnership projects between Catalan & Canadian firms and institutions. Project’s minimum budget: 150,000 euros. Direct and non-refundable grant of up to 200,000 euros. Grant intensity: up to 25-50%, depending on the company’s size and the nature of its activities. Nuclis grants are complementary to various Canadian grants and subsidies, including NRC-IRAP. I invite you to forward this email to companies, researchers and research centres who might be interested in participating. If a Canadian company or research centre is interested in participating but has not yet identified a potential Catalan partner, whether it be for TecnioSpring or Nuclis, please let me know and we can help identify the right partner. Looking forward to collaborating with you very soon! Best regards, Geneviève Abbott Executive Director, Catalonia Trade & Investment Office